← back to search

Hassan Ashktorab

Howard University Hospital · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Colorectal Cancer Screening and Detection, Genetic factors in colorectal cancer, Helicobacter pylori-related gastroenterology studies, and Epigenetics and DNA Methylation.
h-index
54
citations
9,535
works
571
NIH funding
primary concept
Medicine
email

Recent publications

Sex Differences in Long COVID
JAMA Network Open 2025cited by 82position: middledoi
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study
Journal of General Internal Medicine 2025cited by 43position: middledoi
Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort
Nature Communications 2025cited by 8position: middledoi
Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort
JAMA Network Open 2025cited by 3position: middledoi
Age‐Related Changes in the Clinical Picture of Long <scp>COVID</scp>
Journal of the American Geriatrics Society 2025cited by 2position: middledoi
Hypoxia and Hypoxia-Reoxygenation Potentiate Helicobacter pylori Infection and Gastric Epithelial Cell Proliferation.
2025cited by 1position: contributordoi
2024 Update of the RECOVER-Adult Long COVID Research Index
JAMA 2024cited by 64position: middledoi
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.
2024cited by 34position: contributordoi
LOX-1 acts as an N6-methyladenosine-regulated receptor for Helicobacter pylori by binding to the bacterial catalase
Nature Communications 2024cited by 18position: middledoi
Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.
2024cited by 11position: contributordoi
High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer.
2024cited by 4position: contributordoi
Abstract 7462: Interventional dietary saffron drives antitumor immunity inInterventional dietary saffron drives antitumor immunity in high risk colorectal cancer IBD Patients, A Multisite Clinical Trial Study
Cancer Research 2024cited by 1position: firstdoi
Predictors of mortality in hospitalized African American COVID-19 patients with cancer.
2024cited by 1position: contributordoi
Saffron as a Promising Therapy for Inflammatory Bowel Disease.
2024cited by 1position: contributordoi
High Prevalence of Diabetes Among Hospitalized COVID-19 Minority Patients: Data from a Single Tertiary Hospital.
2024cited by 1position: contributordoi
Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.
2024cited by 1position: contributordoi
Correction to: High Prevalence of Diabetes Among Hospitalized COVID-19 Minority Patients: Data from a Single Tertiary Hospital.
2024cited by 0position: contributordoi
Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression
Cancer Cell 2023cited by 84position: middledoi
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
PLoS ONE 2023cited by 56position: middledoi
Comprehensive molecular phenotyping of <i>ARID1A</i>-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.
2023cited by 23position: contributordoi
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations.
2023cited by 11position: contributordoi
Mechanism of Antitumor Effects of Saffron in Human Prostate Cancer Cells.
2023cited by 7position: contributordoi
Microbiomic and Metabolomic Analyses Unveil the Protective Effect of Saffron in a Mouse Colitis Model.
2023cited by 6position: contributordoi
Editorial to the Special Issue 'Nutritional Intervention in Digestive Diseases in the Era of Nutraceuticals, Nutrigenomics and Microbiomics'.
2023cited by 0position: contributordoi
Protective Effect of Saffron in Mouse Colitis Models Through Immune Modulation.
2022cited by 19position: contributordoi
Clinical and Endoscopic Outcomes in Coronavirus Disease-2019 Patients With Gastrointestinal Bleeding.
2022cited by 10position: contributordoi
Saffron, Its Active Components, and Their Association with DNA and Histone Modification: A Narrative Review of Current Knowledge.
2022cited by 10position: contributordoi
Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case-control and cohort studies.
2022cited by 7position: contributordoi
A novel protein AXIN1-295aa encoded by circAXIN1 activates the Wnt/β-catenin signaling pathway to promote gastric cancer progression
Molecular Cancer 2021cited by 191position: middledoi
Saffron and Its Major Ingredients’ Effect on Colon Cancer Cells with Mismatch Repair Deficiency and Microsatellite Instability
Molecules 2021cited by 82position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 34 papers (2019–2025)Hassan Brim · University of Pittsburgh Medical Center10 papers (2016–2025)Duane T. Smoot · Meharry Medical College6 papers (2012–2024) · 4 papers (2019–2021)Mudasir Rashid · Clarivate PLC4 papers (2022–2024)Amr Amin · Cairo University4 papers (2019–2021)Mehdi Nouraie · University of Pittsburgh4 papers (2014–2019)Edward Lee · Rutgers, The State University of New Jersey3 papers (2014–2019)S. R. Sinha · McMaster University3 papers (2021–2023)Giovanni Latella · University of L'Aquila3 papers (2021–2023)Mehdi Nouraie · UPMC Montefiore3 papers (2019–2020)Angelo Viscido · MDPI3 papers (2021–2023)Filippo Vernia · University of L'Aquila3 papers (2021–2023)Ulrike Stein · German Cancer Research Center3 papers (2016–2020)Aida Habtezion · Pfizer (United States)3 papers (2019–2021)John M. Carethers · University of San Diego3 papers (2016–2019) · 3 papers (2016–2024)Adeyinka O. Laiyemo · Georgetown University2 papers (2014–2025)Hassan Brim · Howard University2 papers (2013–2014)Ulrike Stein · American Association for Cancer Research2 papers (2019–2020)